Company: Cameron Health
Based: San Clemente, CA
Investors: Alloy Ventures, Delphi Ventures
Scoop: Cameron Health comes out on top with its $107 million take. The financing is helping the company expand the commercialization of its subcutaneous implantable defibrillator system outside the U.S., submit the premarket approval study to the FDA and expand infrastructure and manufacturing capabilities in preparation for estimated 2013 commercial launch of the system.
The S-ICD system is the first totally subcutaneous implantable defibrillator and is designed to provide life-sustaining therapy to patients at risk of sudden cardiac arrest (SCA).
"We are extremely encouraged by the potential benefits of this new technology," David Douglass, general partner of Delphi Ventures, said in a statement. "We believe Cameron Health has developed an innovative implantable defibrillator that can potentially redefine the clinical treatment of SCA."